baber/WOPTO huggingface dataset:
Patent NZ-241739-A (NZ)
Title: Substituted perhydro-1h-pyrido[1,2-a]pyrazine derivatives and intermediates; pharmaceutical compositions thereof.
Inventor: BRIGHT GENE MICHAEL
IPC: C07D211/62
Filed: 1992-02-26
Abstract: Antipsychotic compounds having the formula   <IMAGE> (I)  wherein Z is H or Cl; Y is O or S; n is 1-4; separately, X is H or (C1-C2)alkyl and L is R(CH2)mCO, m is 0 or 1-3, R is (C1-C6)alkyl, (C3-C7)cycloalkyl, phenyl, naphthyl, furyl, benzofuranyl, thienyl, benzothienyl, pyrrolyl, indolyl, isoindolyl or one of said groups substituted on aromatic or heteroaromatic ring with fluoro, chloro, (C1-C2)alkyl or (C1-C2)alkoxy; or together L and X, in combination with the nitrogen to which they are attached, form certain cyclic imides, 4-substituted piperidines or a cyclic sulfonamide.
Patent NZ-243869-A (NZ)
Title: Geneserine derivatives and pharmaceutical compositions thereof
Inventor: CHIESI PAOLO
IPC: C07D/
Filed: 1992-08-06
Abstract: PCT No. PCT/EP92/01762 Sec. 371 Date Mar. 3, 1994 Sec. 102(e) Date Mar. 3, 1994 PCT Filed Aug. 4, 1992 PCT Pub. No. WO93/03041 PCT Pub. Date Feb. 18, 1993Geneserine homologs of formula I    <IMAGE>  (I)  in which R is a straight or branched C2-C20 alkyl group, a C3-C7 cycloalkyl group, an unsubstituted phenyl or benzyl group, or a phenyl or benzyl group substituted by a C1-C4 alkyl group, a halogen atom or a C1-C4 alkoxy group, or a salt with an organic or inorganic non-toxic acid, exhibit anticholinesterase activity and may be useful in the treatment of Alzheimer disease and other conditions due to a neurological deficiency.
Patent NZ-246713-A (NZ)
Title: Bleaching of sulphate pulp comprising: oxygen delignification, pretreatment with complexing agent, washing then dewatering, and alkaline peroxide bleaching in presence of silicate or an organic complexing agent
Inventor: LINDSTROM LARS-AKE
IPC: D21C9/10
Filed: 1993-01-12
Abstract: A method of bleaching sulphate pulp without using chlorine-containing bleaching agents. The sulphate pulp is oxygen delignified and can possibly also be ozone delignified to a kappa number below 9.5. Thereafter a pretreatment with complexing agent is carried out for 1-60 minutes, at which the pulp consistency is 1-15 %, the temperature 70-110  DEG C and pH 5-7. The pulp thus pretreated is washed and dewatered to a consistency of 18-40 %. Thereafter peroxide bleaching in alkaline environment takes place in the presence of silicate or an organic complexing agent of the type phosphonic or carboxylic acid.
Patent NZ-251678-A (NZ)
Title: Producing a milk-like product by adding transglutaminase to a liquid containing milk protein
Inventor: NIELSEN PER MUNK
IPC: A23C9/127
Filed: 1993-03-26
Abstract: The method for production of a milk like product is characterized by the fact that transglutaminase is added to a liquid containing milk proteins, that the liquid contains Ca<++>, if required, in an amount sufficient for the reaction catalysed by the transglutaminase, and that the pH of the liquid is adjusted to a value of between 2.8 and 5.2. Hereby a milk like product which is physically more stable than the hitherto known milk like products is obtained. Also in case the milk like product is mixed with fruit juice, the thus generated drink remains stable and homogeneous.
Patent NZ-256576-A (NZ)
Title: Anti-inflammatory factor composition derived from milk
Inventor: BECK LEE R
IPC: A61K35/54
Filed: 1993-09-22
Abstract: The invention relates to an anti-inflammatory factor isolated from milk and to methods for using this factor to remove adhered neutrophils from endothelial cells, to prevent the emigration of cells from the vasculature and to suppress the response of lymphocytes to foreign antigens.
Patent NZ-295418-A (NZ)
Title: Targeted cytotoxic lymphocytes, preparation and vaccines thereof
Inventor: STRINGER BRADLEY MICHAEL JOHN
IPC: A61K35/14
Filed: 1995-11-16
Abstract: A targeted cytotoxic T lymphocyte having a TcR comprising heterologous a and b polypeptides, which heterologous polypeptides confer on the lymphocyte MHC Class 1 restricted specificity for disease causing target cells, wherein the T lymphocyte is monovalent, having a single species of TcR conferring MHC Class 1 restricted specificity for a single class of target cells. Also claimed is a method for making these by providing a vector comprising nucleic acid encoding a and b TcR polypeptides specific for disease causing target cells and transfecting a recipient cytotoxic T lymphocyte with the vector to produce a recombinant cytotoxic T lymphocyte having DNA encoding a and b TcR polypeptides specific for disease causing target cells. This is further used as a vaccine to treat AIDS.
Patent NZ-331664-A (NZ)
Title: Apparatus and methods of routing transmission signals
Inventor: TITMUSS RICHARD JOHN
IPC: H04Q3/00
Filed: 1997-03-27
Abstract: Disclosed is a routing apparatus for a telecommunication system comprising: a telecommunications user means arranged to generate a request for a telecommunications delivery service, to receive a plurality of telecommunications delivery service offers and to select one thereof; a plurality of telecommunication service supply means each arranged to receive a said request to generate an offer signal specifying a proposed delivery service; and to receive an acceptance signal indicating acceptance thereof and, on receipt thereof, to generate a service provision invitation; and a plurality of resource supplier means each representing a communications resource arranged to communicate with each of the service supply means, where the resource supplier means is arranged to receive a invitation to determine whether the telecommunications resource they represent would contribute to the provision of the corresponding service; and, if so, to signal this to the service supply means; the service supply means being arranged, on the basis of signals from the resource supplier means, to select the route subsequent to the offer of the service.
Patent NZ-331917-A (NZ)
Title: Non-woven fiber mat and method for forming same
Inventor: HELWIG GREGORY S
IPC: D04H1/46
Filed: 1997-03-19
Abstract: The present invention is a non-woven fibre mat suitable for reinforcing resilient sheet floor coverings, such as vinyl floor coverings.  The woven fibre mat is in the form of a sheet of reinforcement fibres (14) which at least includes semi-coiled fibres (18) and slightly curved fibres (20).  It is desirable for most, if not all, of the reinforcement fibres (14) to be made from glass.  However, it may also be desirable for the reinforcement fibres (14) to include glass fibres and synthetic fibres.  It may even be possible for the reinforcement fibres (14) to include only non-glass fibres.  At least one polymeric binder is used for bonding together the reinforcement fibres (14) so as to make the fibre mat a suitable substrate for reinforcing resilient sheet floor coverings, such as an interlayer for vinyl floor coverings.  By using a non-woven fibre mat containing reinforcement fibres (14) that are not completely straight and capable of interlocking with one another, a resilient sheet floor covering made with such a mat can exhibit improved planar compressibility.
Patent NZ-332294-A (NZ)
Title: Methods for manufacturing moulded hinged starch-based articles having a cellular matrix
Inventor: ANDERSEN PER J
IPC: B29C45/00
Filed: 1997-06-10
Abstract: Methods and systems for forming hinged starch-bound matrices. Starch-based compositions are molded between heated molds in order to form a cellular matrix and also to remove the water from the starch-based compositions in order to form a binding matrix of solidified starch. The molding apparatus is configured to form one or more creases within the hinge area in order to define one or more lines upon which the hinge will bend. The molding apparatus is also configured such that the region of the mold corresponding to the inner surface of the hinge area will transfer heat more slowly to the inner hinge surface, resulting in reduced thickness of the skin of the inner hinge. This increases the collapsibility, or ability of the inner surface of the hinge to fold or buckle, during the bending action. This in turn reduces the bending radius of hinge such that the hinging action exerts less strain on the outer surface of the hinge. The inner surface of the hinge may optionally be treated with glycerin or other polyols to soften the inner surface. The outer surface of the hinge may optionally be coated with an elastomeric material, such as polyvinyl alcohol, in order to strengthen the outer surface and reduce its tendency to fracture during the hinging action.
Patent NZ-333025-A (NZ)
Title: A portable frame suitable for washing, drying and storing diving equipment
Inventor: TE KAHIKA GUY ROBERT EDWARD
Filed: 1998-11-26
Abstract: A portable frame suitable for washing drying and storing diving equipment comprises a base 10 for supporting the frame on a floor or on the ground.  A body 12 extends upwardly from base 10 and an arm 14 extends outwardly from body 12.  A garment hanger 30 or 32 is on arm 14 whereby a wetsuit 34 or other garment can be hung from the garment hanger in an unfolded state.  Spraying means 38 is mounted on the frame and is able to spray a washing liquid completely over the garment hanging from the garment hanger.  Conduit means which can be provided by the frame itself, delivers washing liquid to spraying means 38 and coupling means is for coupling a remote source of washing liquid under pressure to the conduit means.
Patent NZ-334934-A (NZ)
Title: Diresorcinyl-alkoxy- and aryloxy-triazines, a process for their preparation and their use in cosmetic compositions as light protection agents
Inventor: EHLIS THOMAS
IPC: A61Q17/04
Filed: 1999-03-30
Abstract: A compound of the above formula wherein: R1 is C6-C30alkyl, C2-C30alkenyl, unsubstituted or C1-C5alkyl-mono- or polysubstituted C5-C12cycloalkyl, C1-C5alkoxy- C1-C12alkyl, amino- C1-C12alkyl, C1-C5monoalkylamino- C1-C12alkyl, C1-C12dialkylamino- C1-C12alkyl, or a radical as defined in the specification; R2, R3 and R4 independently of one another are hydrogen, hydroxyl, C1-C30alkyl, C1-C30alkenyl; R5 is hydrogen; m1 is 0 or 1; n1 is 1 to 5 Also disclosed are cosmetic preparations containing the above formula as a stabilizer in combination with other UV protective substances such as triazines, oxanilides, triazoles, amides containing vinyl groups or cinnamides and an organic material which is sensitive to damage by light, oxygen and/or heat.
Patent NZ-501454-A (NZ)
Title: Removing a gaseous component from a fluid stream
Inventor: BETTING MARCO
IPC: F25J3/06
Filed: 1998-07-01
Abstract: A method of removing a selected gaseous component from a stream of fluid containing a plurality of gaseous components is provided. The stream is induced to flow at supersonic velocity through a conduit so as to decrease the temperature of the fluid to below a selected temperature at which one of condensation and solidification of the selected component occurs thereby forming particles of the selected component, the conduit being provided with swirl imparting means to impart a swirling motion to the stream of fluid thereby inducing the particles to flow to a radially outer section of a collecting zone in the stream. A shock wave is created in the stream so as to decrease the axial velocity of the fluid to subsonic velocity, and the particles are extracted into an outlet stream from said radially outer section of the collecting zone, wherein the shock wave is created downstream the swirl imparting means and upstream the collecting zone.
Patent NZ-510764-A (NZ)
Title: Processing data using XML to format a user's request specifying a data processing engine and routing the request to the specified data processing engine.
Inventor: WALKER CRAIG MICHAEL
IPC: G06F17/30
Filed: 2001-03-26
Abstract: A method of processing data includes: i) on the occurrence of an application event generating a message in XML specifying a data processing engine to process the message; ii) routing the message to the data processing engine and outputting a response formatted in XML; iii) processing the message by the specified engine and outputting a response formatted in XML and iv) transforming the response to another format according to a format information file. A method for generating formatting information for a formatted page of information includes: i) storing formatting  information in a database; ii) extracting formatting information as an XML file and iii) converting the XML file to define the required information wherein the formatted page is a web page and some formatting information is converted to a Cascading  Style Sheet to define background information for the web page, some of the formatting information is in XML format and defines foreground information for the web page and some formatting information is in XML format and defines data content for the web page.
Patent NZ-511972-A (NZ)
Title: Active arterial embolization filter
Inventor: RICHTER JACOB
IPC: A61M29/00
Filed: 2001-05-25
Abstract: Apparatus for collecting emboli flowing in a lumen.  A motor (1) has a longitudinal bore, a friction area within the longitudinal bore, and a guide wire (2) disposed within the longitudinal bore.  The guide wire and friction area of the motor are sized and adapted to contact each other and impart friction between the friction area and the guide wire to permit the motor to rotate around the guide wire.  A thrombus-collecting gutter (16) is attached to the motor.  Paddles (8) are attached to the motor and are adapted to initiate a spiral blood flow when the motor rotates.  The spiral blood flow causes thrombi in the blood to deflected towards the internal wall of the lumen and be trapped in a thrombus collecting gutter which is positioned on the motor downstream of the paddles.
Patent NZ-514711-A (NZ)
Title: Compounds useful as anti-inflammatory agents
Inventor: BETAGERI RAJASHEKHAR
IPC: C07D307/12
Filed: 2000-02-16
Abstract: A compound of formula (1); its preparation thereof; and use in treating disorders mediated by cytokines.
Patent NZ-523086-A (NZ)
Title: Method of administering bisphosphonates
Inventor: HOROWITZ ZEBULUN D
IPC: A61K9/50
Filed: 2001-06-18
Abstract: Use of 1-hydroxy-2-(imidazol-1-yl)ethane-1, 1-diphosphonic acid or a pharmaceutically acceptable salt thereof or any hydrate thereof in the manufacture of a medicament for the treatment of conditions of abnormally increased bone turnover in which the 1 -hydroxy-2-(imidazol-1-yl)ethane-1, 1-diphosphonic acid or a pharmaceutically acceptable salt thereof or any hydrate thereof is administered intermittently and which the period between administrations is at least about 6 months.
Patent NZ-523338-A (NZ)
Title: New polycyclic xanthones and their use as antitumor agents
Inventor: PEREZ-BAZ JULIA
IPC: C12N1/20
Filed: 2001-06-29
Abstract: A process is described for producing the compound IB-00208, shown in formula 3. This comprises cultivating a strain of a microorganism capable of producing it in an aqueous nutrient medium, and is described to be used in the manufacture of a medicament for the treatment of cancer. Also depicted is a compound of the general formula 1 or 2 where each R1 is the same or different and can be hydrogen, acyl, alkyl, alkenyl, aryl, benzyl, alkali metal, and/or sugar; and R2 and R3 can be hydrogen, alkyl, or together R2 and R3 form an unsaturated bond.
Patent NZ-523852-A (NZ)
Title: AZA-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
Inventor: DYATKIN ALEXEY B
IPC: A61P37/02
Filed: 2001-06-29
Abstract: Aza-bridged-bicyclic compounds of formula (I) useful as 4 integrin receptor antagonists and in particular 41 and 47 integrin receptor antagonists. Also disclosed is the use of such compounds in the preparation of a medicament for the treatment of an integrin mediated disorder ameliorated by inhibition of an 4 integrin receptor in a subject in need thereof.
Patent NZ-524633-A (NZ)
Title: 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
Inventor: LANGE JOSEPHUS H M
IPC: A61P25/22
Filed: 2002-03-18
Abstract: The enantiomer having S configuration at the 4-position of their 4,5-dihydropyrazole ring of a compound of formula (I), pharmaceutical composition comprising the compound of formula (I) and its use in the preparation of a pharmaceutical for the treatment of psychiatric disorders or gastrointestinal disorders and cardiovascular disorders involving cannabinoid neurotransmission.
Patent NZ-525207-A (NZ)
Title: Nucleic acids encoding stichodactylidae chromoproteins
Inventor: LUKYANOV SERGEY ANATOLIEVICH
IPC: C07K14/47
Filed: 2001-10-12
Abstract: A nucleic acid composition which encodes a far red shifted Stichodactylidaen chromoprotein or fluorescent mutant thereof.
Patent NZ-526024-A (NZ)
Title: Inhalative propellant-free solution formulation containing a tiotropium salt
Inventor: DRECHSEL KARIN
IPC: A61K31/56
Filed: 2001-10-24
Abstract: A liquid propellant-free pharmaceutical preparation comprises a tiotropium salt as one active substance, in a concentration based on tiotropium of between 0.0005 and 5 % by weight, a second active substance selected from antiallergics, antihistamines, steroids and/or leukotriene antagonists, water or a water/ethanol mixture as solvent, in which at least the tiotropium salt is dissolved, an acid for achieving a pH between 2.0 and 3.1, a preservative, and optionally a complexing agent, stabilizer, cosolvent and/or other adjuvants and additives in addition to the preservative. The pharmaceutical preparation can be used as a medicament for the treatment of asthma and/or COPD for administration by inhalation.
Patent NZ-530822-A (NZ)
Title: Fungicidal triazolopyrimidines, method for the production thereof and use thereof in controlling noxious fungi and agents containing said compounds
Inventor: MULLER BERND
IPC: C07D487/04
Filed: 2002-07-03
Abstract: A triazolopyrimidine of formula I; a process for preparing the formula; and a method for controlling harmful fungi comprising treating the fungi or the materials, plants, the soil or the seeds to be protected against fungal attack with an effective amount of a compound.
Patent NZ-539188-A (NZ)
Title: Phenolic resin-based adhesives and methods of using same in preparing laminated veneer lumber (LVL)
Inventor: WILLIAMSON BOBBY L
IPC: B32B21/14
Filed: 2005-04-04
Abstract: Adhesive compositions and methods of using the compositions in the production of laminated veneer lumber (LVL) are disclosed. The adhesive compositions comprise a thermosetting phenol-aldehyde resin having at least one of (A) a number average molecular weight (Mn) of at least about 450, (B) a weight average molecular weight (Mw of at least about 2000, and (C) a Z-average molecular weight (Mz) of at least about 6000, wherein said Mn, Mw, and Mz are measured using gel permeation chromatography (GPC), a ketone-aldehyde resin cure promoter, and optionally other components (e.g., a tack-promoter or a catalyst). The adhesive compositions minimize or eliminate the art-recognized problems of glue line dryout and steam blowout, associated with LVL manufacture from both low-moisture veneers and high-moisture veneers, respectively. Furthermore, the adhesive compositions provide fast tack-build and curing as well as ultimately good bonding characteristics.
Patent NZ-543712-A (NZ)
Title: Combination therapy for B cell disorders
Inventor: CHAN ANDREW
IPC: A61K39/395
Filed: 2004-06-04
Abstract: Disclosed is the use of an anti-CD20 antibody with a BLyS antagonist in treating B cell disorders.
Patent NZ-547557-A (NZ)
Title: Pharmaceutical compositions containing a cationic A2A receptor antagonist
Inventor: HEIMBECHER SUSAN K
IPC: A61K31/505
Filed: 2004-12-17
Abstract: Disclosed is a pharmaceutical formulation comprising the compound of Formula I, ion-paired with sodium docusate, thereby forming a complex soluble in a non-aqueous solvent. Also disclosed is a formulation comprising a compound of Formula I, a non-ionic surfactant, a polyoxyethylene castor oil derivative, propylene glycol, hydrochloric acid, and an anionic surfactant, wherein the compound of Formula I is ion-paired with the anionic surfactant in the composition.
Patent NZ-550895-A (NZ)
Title: Heat-shrinkable multilayer films
Inventor: BERNIG WALTER
IPC: B32B27/32
Filed: 2005-04-19
Abstract: Disclosed are heat-shrinkable multilayer films comprising a surface layer that is based on at least one olefinic polymer and/or copolymer, a layer based on a mixture of an ionomer having a maximum MFI of 4dg/min and an ionomer having an MFI greater than 4dg/min, a barrier layer based on polyvinylidene chloride or a vinylidene chloride polymer, a layer based on said ionomer mixture or an olefinic copolymer, and a sealing layer which is composed of at least one polyolefin or olefinic copolymer, preferably as tubular film. Also disclosed are the use thereof as a packaging and the corresponding tubular film packagings.
Patent NZ-553106-A (NZ)
Title: Performing motion capture using shutter synchronization of cameras and phosphorescent paint applied to a performer
Inventor: LASALLE GREG
IPC: G06T15/10
Filed: 2005-09-26
Abstract: Disclosed is a system used for performing motion capture. The system comprises a synchronization signal generator to generate one or more synchronization signals; a light source configured to strobe on and off responsive to a first one of the one or more synchronization signals; and a plurality of cameras having shutters strobed at a uniform strobing rate synchronously with the strobing of the light source to capture images of phosphorescent paint. The light source charges the phosphorescent paint which has been applied to specified regions of a performer's face and/or body for a motion capture session. The cameras' shutters are open when the light source is off and closed when the light source is on. A method of carrying out this motion capture is also disclosed.
Patent NZ-555460-A (NZ)
Title: Quinoline derivatives for the treatment of latent tuberculosis
Inventor: ANDRIES KOENRAAD JOZEF LODEWIJK MARCEL
Filed: 2005-12-08
Abstract: Provided is the use of a compound of formula (Ia) or (Ib) for the manufacture of a medicament for the treatment of latent tuberculosis, wherein the compound of formula (Ia) or (Ib) is a pharmaceutically acceptable salt, a quaternary amine, a N-oxide, a tautomeric form or a stereochemically isomeric form thereof wherein R1 is hydrogen, halo, haloalkyl, cyano, hydroxy, Ar, Het, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl; p is 1,2,3 or 4. R1 is hydrogen, hydroxy, mercapto, alkyloxy, alkyloxyalkyloxy, alkylthio, mono or di(alky1)amino or a radical of formula (II). R3 is alkyl, Ar, Ar-alkyl, Het or Het-alkyl; q is zero, 1, 2,3 or 4; R4 and R5 each independently are hydrogen, alkyl or benzyl; or R4 and R5 may be taken together including the N to which they are attached; R6 is hydrogen, halo, haloalkyl, hydroxy, Ar, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl; or two vicinal R radicals may be taken together to form a bivalent radical -CH=CH-CH=CH-; r is 1, 2, 3,4 or 5 ; R7 is hydrogen, alkyl, Ar or Het; R8 is hydrogen or alkyl; R9 is oxo; or R8 and R9 together form the radical =N-CH=CH-.
Patent NZ-566774-A (NZ)
Title: Human monoclonal antibodies to activin receptor-like kinase-1
Inventor: NORTH MICHAEL AIDAN
IPC: C07K16/40
Filed: 2006-09-06
Abstract: Disclosed is monoclonal antibody or antigen-binding portion thereof, that binds ALK-1: a) wherein the heavy chain CDR 1, CDR2, and CDR3 sequences of the antibody are the CDR 1, CDR2, and CDR3 amino acid sequences, respectively, of the heavy chain variable domain of SEQ ID NO: 6, 14, 18, 26, 30, 38, 46, 50, 54, 58, 62, 66, 70, or 104; and b) wherein the light chain CDR1, CDR2, and CDR3 sequences of the antibody are the CDR 1, CDR2, and CDR3 amino acid sequences, respectively, of the light chain variable domain of SEQ ID NO: 8, 16, 20, 28, 32, 40, 48, 52, 56, 60, 64, 68, 72, or 127. Also disclosed is the use of the antibody in the manufacture of a medicament for treating cancer and for inhibiting angiogenesis in a mammal.